Mefloquine tolerability during chemoprophylaxis: Focus on adverse event assessments, stereochemistry and compliance

Tropical Medicine and International Health

Volumn 1, Issue 4, 1996, Pages 485-494

  Schlagenhauf, P ^a   Steffen, R ^a   Lobel, H ^b   Johnson, R ^c   Letz, R ^d   Tschopp, A ^a   Vranjes, N ^a   Bergqvist, Y ^e   Ericsson, O ^f   Hellgren, U ^f   Rombo, L ^f   Mannino, S ^g   Handschin, J ^h   Sturchler D ^h  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c US Army Res Inst of Environ Med   (United States)

^d EMORY UNIVERSITY   (United States)

^e FALUN HOSPITAL   (Sweden)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g UNIVERSITY OF CHIETI   (Italy)

^h F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Adverse event; Mefloquine

Indexed keywords

MEFLOQUINE;

AFRICA; ARTICLE; DISTRESS SYNDROME; ENDEMIC DISEASE; HUMAN; INFECTION PREVENTION; MALARIA; PHOBIA; PLASMODIUM FALCIPARUM; SLEEP DISORDER; TREATMENT OUTCOME; VERTIGO;

PLASMODIUM FALCIPARUM;

EID: 9444226519     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.1996.d01-85.x     Document Type: Article

References (32)

1. Baker EL, Letz R, Eisen E et al (1988) Neurobehavioural effects of solvents in construction painters. Journal of Occupational Medicine 30, 116-123.
2. Baker EL, Letz R & Fidler AT (1985) A computer-administered neurobehavioral evaluation system for occupational and environmental epidemiology. Journal of Occupational Medicine 17, 116-123.
3. Basco LK, Gillotin C, Gimenez F et al (1992) In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum. British Journal of Clinical Pharmacology 33, 517-520.
4. Bem JL, Kerr L & Stürchler D (1992) Mefloquine prophylaxis: an overview of spontaneous reports of severe psychiatric reactions and convulsions. Journal of Tropical Medicine and Hygiene 95, 86-91.
5. Bergqvist Y, Hellgren U & Churchill FC (1989) High-performance liquid Chromatographic assay for the simultaneous monitoring of mefloquine and its acid metabolite in biological samples using protein precipitation and ion-pair extraction, Journal of Chromatography 432, 263-263.
6. Boudreau E, Schuster B, Sanchez J et al (1993) Tolerability of prophylactic Lariam regimens. Tropical Medicine and Parasitology 44, 257-265.
7. Bradley D (1993) Prophylaxis against malaria for travellers from the United Kingdom. British Medical Journal 306, 1247-1252.
8. Centers for Disease Control (1994) Health Information for International Travel. US Department of Health and Human Services, Atlanta.
9. Coole L, Wiselka MJ & Nicholson KG (1989) Malaria prophylaxis in travellers from Britain. Journal of Infect 18, 209-212.
10. Fidler AT, Baker EL & Letz R (1987) The neurobehavioural effects of occupational exposure to organic solvents among construction painters. British Journal of Industrial Medicine 44, 291-308.
11. Gimenez F, Pennie RA, Koren G, Crevoisier C et al (1994) Stereoselective pharmacokinetics of mefloquine in healthy Caucasians after multiple doses. Journal of Pharmaceutical Science 83, 824-827.
12. Hakansson A, Landberg-Lindgren A & Bjorkman A (1990) Comparison of the activity in vitro of mefloquine and two metabolites against Plasmodium falciparum. Transactions of the Royal Society of Tropical Medicine and Hygiene 84, 503-504.
13. Haynes RB & Sacken DL (eds) (1976) Compliance with therapeutic regimens. Johns Hopkins University Press, Baltimore.
14. Johnson R, Branch LG & McMenemy DJ (1989) Influence of attitude and expectation on moods and symptoms during cold weather military training. Aviation Space and Environmental Medicine 60, 1157-1162.
15. Letz R (1991) Use of computerised test batteries for quantifying neurobehavioural outcomes. Environmental Health Perspectives 90, 195-198.
16. Lobel HO, Miani M, Eng T, Bernard KW, Hightower AW & Campbell CC (1993) Long-term malaria prophylaxis with weekly mefloquine. Lancet 341, 848-851.
17. Lobel HO, Phillips-Howard PA, Bradling-Bennett AD et al (1990) Malaria incidence and prevention among European and North American travellers to Kenya. Bulletin of the World Health Organization 68, 209-215.
18. Mazzulo JM & Lasagna L (1972) Take thou . . . but is your patient really taking what you prescribed? Drug Therapy 2, 11-15.
19. McNair DM & Droppelman ML (1981) EITDS Manual for the Profile of Mood States Educational and Industrial Testing Service, San Diego, CA.
20. Ngiam TL & Go MI. (1987) Stereoselective inhibition of cholinesterases by mefloquine enantiomers. Chemical Pharmacology Bulletin 35, 409-412.
21. Phillips-Howard PA, Radalowicz A, Mitchell J & Bradley DJ (1990) Risk of malaria in British residents returning from malarious areas. British Medical Journal 300, 499-505.
22. Raeber PA et al (1992) Prophylaxie du Paludisme 1991: cinq remarques d'actualité. Med Hygiene 49, 3214-3216.
23. Rubin R, Orris P, Lau S et al (1991) Neurobehavioural effects of the on-call experience in housestaff physicians. Journal of Occupational Medicine 33, 13-18.
24. Sampson JB & Kobrick JL (1980) The Environmental Symptoms Questionnaire. Revisions and new field data. Aviation, Space and Environmental Medicine 51, 872-877.
25. Sampson JB, Kobrick JL & Johnson RF (1994) Measurement of subjective reactions to extreme environments: The Environmental Symptoms Questionnaire. Military Psychology 6, 215-233.
26. Steffen R, Fuchs E, Schildknecht J et al (1993) Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa. Lancet 341, 1299-1303.
27. Steffen R & Schlagenhauf P (1993) Malaria chemoprophylaxis. Letter. Lancet 342, 502.
28. Stürchler D, Handschin J, Kaiser D, Kerr L, Mittelholzer ML, Reber R et al (1990) Neuropsychiatric side effects of mefloquine. Letter. New England Journal of Medicine 322, 1753.
29. von Kessel RPM & Lilijveld JLM (1992) Compliance with preventive measures against malaria by visitors to the vaccination centre of the Utrecht municipal health services. World Health Organization MAL 92, 1066.
30. Wallén L, Ericsson O, Wikström I & Hellgren U (1994) High-performance liquid Chromatographic method for the enantioselective analysis of mefloquine in plasma and urine, Journal of Chromatography 655, 153-157.
31. Weinke T, Trautman M, Held T et al (1991) Neuropsychiatric side effects after the use of mefloquine. American Journal of Tropical Medicine and Hygiene 47, 1-5.
32. World Health Organisation (1995) International travel and health. Vaccination requirements and health advice. World Health Organisation, Geneva.